What is Delix Therapeutics worth?
$156.2Mlast known valuation
Delix Therapeutics last raised $70.0M in its Early Stage VC (Series A) (Sep 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 40 names
- ·Watchlist + deal alerts for Delix Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2021 | Early Stage VC (Series A) | $70.0M | ▮ | ▮ |
How Delix Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Delix Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Delix Therapeutics worth?
- Delix Therapeutics's last known valuation is $156.2M.
- How much has Delix Therapeutics raised?
- Delix Therapeutics has raised $108.5M in total funding across 1 recorded rounds.
- When did Delix Therapeutics last raise?
- Delix Therapeutics last raised in Sep 2021 (Early Stage VC (Series A)), raising $70.0M.